Skip to content

Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis

Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02769546
Enrollment
50
Registered
2016-05-11
Start date
2016-01-31
Completion date
2018-01-31
Last updated
2020-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Brief summary

The primary objective is to administer a cross-sectional survey to directly compare the differences patients and physicians hold regarding ovarian cancer prognosis and survival, complications arising from treatment, and counseling on advance directives, living wills, palliative care, and hospice services. Overall, the project will pinpoint opportunities for better patient physician communication regarding prognosis and end-of-life care and allow for more informed and tailored decision-making.

Interventions

OTHERSurveys

Sponsors

Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* women over 18 years old with biopsy-confirmed malignancy * being actively treated or are in surveillance for epithelial ovarian cancer * have an existing therapeutic relationship with a provider who is participating in the study.

Exclusion criteria

* patients enrolled in palliative or hospice care programs, patients with a second primary malignancy within the last five years (excluding non-melanoma skin cancer) * patients who are illiterate or non-English speaking, and patients without decision-making capacity. * There are no

Design outcomes

Primary

MeasureTime frame
Number of completed surveys and phone interviews1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026